Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · Real-Time Price · USD
3.550
+0.510 (16.78%)
At close: Jun 29, 2026, 4:00 PM EDT
3.480
-0.070 (-1.97%)
After-hours: Jun 29, 2026, 4:22 PM EDT
Perspective Therapeutics Stock Forecast
Stock Price Forecast
The 11 analysts with 12-month price forecasts for Perspective Therapeutics stock have an average target of 12.82, with a low estimate of 6.00 and a high estimate of 18. The average target predicts an increase of 261.13% from the current stock price of 3.55.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Perspective Therapeutics stock from 15 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 12 | 12 | 12 | 12 | 12 | 12 |
| Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 15 | 15 | 15 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Maintains $11 | Buy | Maintains | $11 | +209.86% | Jun 4, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $16 | Buy | Maintains | $16 | +350.70% | Jun 1, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $13 | Buy | Reiterates | $13 | +266.20% | Jun 1, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $13 | Buy | Reiterates | $13 | +266.20% | Jun 1, 2026 |
| Bank of America Securities | Bank of America Securities | Hold Maintains $6 | Hold | Maintains | $6 | +69.01% | Jun 1, 2026 |
Financial Forecast
Revenue This Year
417.74K
from 884.00K
Decreased by -52.74%
Revenue Next Year
487.54K
from 417.74K
Increased by 16.71%
EPS This Year
-1.13
from -1.40
EPS Next Year
-1.13
from -1.13
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.1M | 1.3M | |
| Avg | 417,740 | 487,540 | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 20.0% | 204.7% | |
| Avg | -52.7% | 16.7% | |
| Low | -100.0% | -100.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.96 | -0.90 | |
| Avg | -1.13 | -1.13 | |
| Low | -1.37 | -1.38 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.